InSphero



View all Products

3D InSight™ Human Liver Microtissues
A long-lived, organotypic 3D human liver model for more predictive in vitro toxicity assessment. Generated by co-culture of primary hu...

View Product

Dainippon SCREEN Cell3iMager
A rapid, robust imager for monitoring spheroid growth and morphology. The Dainippon SCREEN Cell3iMager provides estimated values regar...

View Product

GravityPLUS™ 3D Culture and Assay P...
The industry-leading solution for reliable, scaffold-free 3D cell-based assays. The InSphero GravityPLUS™ platform makes reliable, aut...

View Product

3D InSight™ Cytotoxicity Assay Kit
A luminescent ATP assay for monitoring cell viability in 3D microtissues. The 3D InSight™ Cytotoxicity Assay Kit is a homogeneous bioch...

View Product

3D InSight™ Pancreatic Microislets
Long-lived, standardized pancreatic islet microtissues for diabetes & metabolic research. 3D InSight™ Human and Rat Pancreatic Microisl...

View Product

Browse All InSphero Products (see all)

Browse Products by Field

Basic Research (5)

General Lab (1)

Lead Discovery (2)

Life Sciences (5)

Pre-Clinical Development (9)

Target Discovery (5)




Company Profile


InSphero is a leading supplier of organotypic, biological microtissues for biomimetic drug testing. The company, headquartered in Zurich, Switzerland, currently collaborates with more than ten global pharmaceutical and cosmetics companies to implement the company’s patent-pending microtissue technology in the customer’s development work-flow. InSphero is a spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich and was founded in 2009 by Dr. Jan Lichtenberg, Dr. Jens Kelm, Dr. Wolfgang Moritz and Prof. Dr. Dr. Simon P. Hoerstrup. InSphero has its production, laboratory and office space at the Technopark in Zurich, Switzerland. InSphero was recognized for its scientific and commercial achievements with a number of awards, including the VentureKick award, Heuberger Entrepreneurial Award and CTIstartup certification.

InSphero’s founders combine more than 15 years of experience in microtissue engineering and over 10 years in microfluidics and laboratory automation with the goal to deliver highly functional, reliable and easy-to-use microtissues.